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TransgenicEarlier studies indicated that transgenic (tg) mice engineered to express prion protein (PrP) lacking the
glycophosphatidylinositol (GPI−/−) membrane anchor formed abnormal proteinase-resistant prion (PrPsc)
amyloid deposits in their brains and hearts when infected with the RML strain of murine scrapie. In contrast,
RML scrapie infection of normal mice with a GPI-anchored PrP did not deposit amyloid with PrPsc in the brain
or the heart. Here we report that scrapie-infected GPI−/− PrP tg mice also deposit PrP and transmissible
infectious material in the gut, kidneys, and islets of Langerhans. Similar to previously reported amyloid
deposits in the brain and heart, amyloid deposits were found in the gut; however, no amyloid deposited in the
islets. By high-resolution electron microscopy, we show PrP is located primarily in α cells and also β cells.
Islets contain abundant insulin and there is no abnormality in glucose metabolism in infected GPI−/− PrP tg
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Scrapie, transmissible spongiform encephalopathies, or prion dis-
eases are known clinically for causing a progressive fatal neurodegen-
erative illness involving humans and animals. Biochemically, these
disorders are characterized by conversion of the normal host cellular
proteinase-sensitive protein (PrPc) to the disease associated formof PrP
that is proteinase resistant (PrPsc). Biologically this protein-folding
disease is associated with production and transmission of infectivity of
tissue containing the PrPsc to normal recipients bearing the same
species PrPc.
Previously we generated transgenic mice in which a stop codonwas
engineered at the COO− end of the PrPc so that the terminal 21 amino
acids were not translated creating a PrP lacking its glycophosphatidy-
linositol (GPI) membrane anchor (Chesebro et al., 2005). This construct
was fused to the PrPc promoter and knocked into mice that previously
had their PrP gene knocked-out (Bueler et al., 1993; Manson et al.,
1994). Such transgenic mice, termed GPI−/− PrP tg mice, lived normaluneventful life spans (600 to 700 days) and reproduced normally
(Chesebro et al., 2005). Intracerebral (i.c.) inoculation of GPI−/− PrP tg
micewith any of several strains ofmurine scrapie (RML [Chandler],ME7
or 22 L) resulted in the conversion of PrPc to PrPsc and the generation of
infectious transmissible material. However, despite abundant deposits
of the abnormally folded PrPsc that quantitatively and signiﬁcantly
exceeded PrPsc deposits formed in scrapie-infected mice with a
membrane-anchored PrP, these scrapie-infected GPI−/− PrP tg mice
failed to develop progressive fatal neurodegenerative disease reminis-
cent of scrapie infection. Instead, they lived normal life spans of 600 to
700 days but displayed abnormalities in CNS electrophysiology and
cognitive learning (Triﬁlo et al., 2008). In contrast, control mice with a
membrane-anchored PrPc developed the expected progressively fatal
neurodegenerative disease by 150 to 180 days post-scrapie challenge.
Two other interesting and novel ﬁndings were observed in scrapie-
infected GPI−/− PrP tg mice. First, the non-amyloid PrPsc deposits
accompanying RML infection of GPI membrane-anchored mice con-
verted to PrPsc deposits as amyloid plaques in mice having a non-
membrane-anchored PrPc indicating that the GPI anchor plays a role in
pathogenesis of prion disease and amyloid deposits (Chesebro et al.,
2005; Triﬁlo et al., 2006). Interestingly, similar amyloid deposits noted
in theGPI−/−PrP tgmicehavebeen recently reported for humanswitha
mutation in their GPI anchor (Jansen et al., 2010). Second, in addition to
theCNSPrPsc/amyloid deposits occurring inGPI−/− PrP tgmice infected
with scrapie, these mice also displayed extraneural manifestations of
PrPsc amyloid deposits in their hearts (Triﬁlo et al., 2006). As a result,
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PrP tg mice but not uninfected GPI−/− PrP tg mice failed to handle an
increase in ﬂuid load leading to heart failure (Triﬁlo et al., 2006).
This paper explores other extraneural manifestations that occur in
GPI−/− PrP tg mice infected with RML scrapie, with a focus on the PrP
deposits in the gut, kidney, and pancreas. In the gut PrPsc deposits,
amyloid and infectious transmissible material was noted. In the kidney
PrPscwas found in focal areas of the glomeruli and in the urine. Further,
infectivity was transmitted from the urine. For the pancreas, PrP was
located in the islets of Langerhansandnot the acinar cells. Utilizinghigh-
resolution immuno-electronmicroscopy, PrPwas foundprimarily in the
α-cells and, to a lesser extent, β-cells of the islets but with a clear
absence of amyloid deposits. Themorphology and numbers ofα- andβ-
cells appear normal. Such scrapie-infected GPI−/− PrP tg mice showed
normal blood glucose levels, glucose tolerance tests, and insulin in the
islets. Lastly, infectious transmissible material was found in the islets.
Results
Extraneural manifestations of scrapie infection
Twenty 8 to 10 week old GPI−/− PrP tg mice were infected i.c. with
RML scrapie and followed for 400 days to determinewhether there was
conversion of PrP found at multiple extraneural sites. Similarly assayed
were ten age- and sex-matched GPI−/− PrP tg mice not receiving
scrapie. As shown in Fig. 1 byWestern blot, scrapie-infected GPI−/− PrP
tg mice converted PrPc to PrPsc in their kidneys, spleen, pancreas, eye,
skeletal muscle, heart, gut, and brain. Conversion to PrPsc occurred at
this time in 18 of 20 (90%) of the scrapie-infected GPI−/− PrP tg mice in
the kidney, pancreas, eye, skeletal muscle and heart, and in 20 of 20
(100%) in the gut and brain (data not shown). PrPsc conversion from
PrPc was not detected in the thymus of these mice. As Fig. 1 illustrates,
the PrPsc was mono-glycosylated (by Western blot) which corre-
sponded to our early observationswith brain and heart (Chesebro et al.,
2005; Triﬁlo et al., 2006, 2008). None of the tissues obtained from
uninfected GPI−/− PrP tgmice displayed PrPsc by eitherWestern blot or
immunohistochemistry (data not shown).
Next,we limitedour focus to studies of thegut, kidney, andpancreas.
Since GPI−/− PrP tg mice infected with RML scrapie expressed PrPsc
with amyloid deposits in their hearts and brains, we analyzed the gut
from all twenty infected mice for PrPsc-associated amyloid deposits. AsFig. 1. PrPsc deposition in extraneural tissues. Western blots showing PrPsc in various tissu
post-infection, and homogenized to a 2% ﬁnal concentration. All samples were treated wi
monoclonal anti-PrP antibody at 1:300. Brain homogenate from an infected B6 mouse is shseen in Fig. 2A, PrPsc (PrPres) occurred as amyloid deposits. This was
observed in all twenty PrPsc-infected GPI−/− PrP tg mice, but PrPsc and
amyloid were absent in all ten GPI−/− PrP tg non-scrapie-infected
controlmice studied. Infectiousmaterialwas found in the gut tissue and
feces by i.c. transmission to sentinel B6 mice resulting in their
developing clinical scrapie 160 to 170 days post-inoculation (data not
shown). Additionally, gut tissuewas transmitted i.c. to tga20micewhich
developed clinical scrapie 60 to 70 days post-infection, conﬁrmed by
ﬁnding PrPsc by Western blot analysis (Fig. 2B). Glomeruli and tubules
in the kidney showed PrPsc by immunohistochemistry in GPI−/− PrP tg
mice infected with scrapie (Fig. 2C). A 10% cleared suspension of either
kidney or urine (Fig. 2D) transmitted infectivity to brains of B6 mice
within 170 days following i.c. inoculation. Western blots conﬁrmed the
presence of fully glycosylated PrPsc in the recipient brain tissue
(Fig. 2D). For the glomeruli, by immunohistochemistry only focal
areas of PrPsc were noted, usually encompassing 10% to 20% of the
glomerular tuffs but on occasion up to 30%. There was no associated
protein in the urine in any of the scrapie-infected mice supporting the
histopathological picture of essentially normal anatomical morphology
of the kidney in scrapie-infected mice whose PrP was not anchored.
In summary, these results indicate that extraneural deposits of
PrPsc occurred in multiple tissues including kidney, spleen, pancreas,
eye, skeletal muscle, and gut. Two excreted sources, urine and feces
from these infected mice, transmitted infectivity to donor mice, as did
extraneural tissue expressing PrPsc. Lastly, PrPsc occurred as amyloid
deposits in the gut. Following these studies, we focused our attention
on the pancreas.
Pancreas deposits PrP and contains transmissible infectious material
Heavy deposits of PrP were found in islets of Langerhans but not
the acinar cells of the pancreas (Fig. 3). In the mice, heavy
concentrations of insulin were also noted (Fig. 4). To address whether
the PrP deposited in the pancreas is infectious, we harvested both
brain (positive control) and pancreatic tissue from ﬁve GPI−/− PrP tg
mice at 400 days post-scrapie infection. Tissue was homogenized and
then injected intracranially into either tga20mice, which express 4- to
6-fold higher levels of PrP than normal mice and develop clinical
symptoms of prion disease 55–70 days post-infection, or into C57Bl/6
recipient mice that developed disease 155–170 days post-infection.
With each of the ﬁve homogenates from the pancreas, both tga20 ande homogenates from the infected GPI−/− PrP tg mouse. Tissues were taken at 400 days
th 25 μg/mL proteinase K prior to SDS-PAGE, and were blotted for PrP using the D18
own as a control.
Fig. 2. (A) PrPsc (PrPres) staining in the gut by immunohistochemistry. Sections of gut tissue from GPI−/− PrP tg mice were stained for PrPsc and amyloid by D18 and Thioﬂavin S
staining, respectively (50×magniﬁcation). Note that PrPsc appears to deposit exclusively as amyloid in the gut. Uninfected control stains are shown on the right (50×magniﬁcation).
(B) Western blot of brain homogenates of tga20 mice infected with either infected B6 brain homogenate or infected GPI−/− PrP tg mouse gut homogenate. Proteinase K digestion
conﬁrms that the PrP in the tga20 brain is PrPsc. (C) Immunohistochemical staining of the kidney reveals PrPsc deposition in the glomerulus after 400 days of infection (400×
magniﬁcation). An uninfected GPI−/− PrP tg mouse kidney is shown as a control (400× magniﬁcation). (D) Urine and kidney tissue were taken 400 days post-infection and was
transferred into B6mice by intracranial inoculation. Both the urine and kidney samples contained PrPsc, as shown byWestern blot, andwere able to pass infection into a B6mouse, as
shown by the development of a proteinase K-resistant band pattern of PrP in the brain tissue of the mouse. The B6 mice also succumbed to disease after 163 days of infection, ﬁtting
with previous observations of PrP infection in B6 mice.
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expected, brain tissue from these mice was also positive for PrPsc by
Western blot (Fig. 5) and transmitted infectious material.PrP deposits in the pancreatic islets of infected GPI−/− PrP tg mice
Fifteen infected GPI−/− PrP tg mice were sacriﬁced at 400 days
post-infection and pancreatic tissue was stained for PrPsc using the
human anti-PrP antibody D13. As controls, ﬁve PrP−/− tg mice and
ﬁve GPI−/− PrP tg mice not infected with scrapie were also sacriﬁced
at 400 days post-infection, as well as ﬁve B6 mice infected with
scrapie and sacriﬁced at day 155 to 170 post-infection when they
displayed progressive CNS signs. In the GPI−/− PrP tg mice, there is a
large amount of PrP expressed in the islets of Langerhans but not in
the acinar cells (Fig. 3). Despite multiple attempts, we were unable to
consistently totally remove PrPc by proteinase K digestion to ensure
that there was PrPsc conversion. Despite using concentrations of
proteinase K as high as 50 μg/mL for as long as 2 h, all the PrPc was not
removed. PrP was only detectable in GPI−/− PrP tg mice and we found
no PrP staining in the infected B6 pancreas. There was no PrP found in
the islets of PrP−/− mice. These ﬁndings, coupled with the infectivity
data below (Fig. 5), indicate the presence of PrPc in the islets of
Langerhans and lead to the assumption that subsequent conversion of
PrPc to PrPsc allows the presence of infectious transmissible material
in the pancreas. Neither PrP nor infectious transmissible material wasfound in B6mice, either uninfected or infected with RML scrapie, or in
PrP−/− mice.
Deposition of PrP in islets does not affect insulin production or glucose
metabolism
A possible consequence of PrPsc deposition in the islets is a
reduction in the production of insulin. Using double immunoﬂuores-
cence staining (Oldstone et al., 1983), we looked for both insulin and
PrP in the islets of GPI−/− PrP tg mice infected with scrapie. As shown
in Fig. 4, there was signiﬁcant production of insulin in the islets
despite the presence of PrP. As a result, deposition of PrP in the islets
did not lead to an imbalance of glucose metabolism. Glucose
metabolism was tested by two methods. First, mice were bled 220
and 400 days after infection with scrapie to assess blood glucose
levels. At 220 days, scrapie-infected GPI−/− PrP tg mice had blood
glucose levels of 142±8 mg/dL (n=19, mean±SEM), while unin-
fected GPI−/− PrP tg control littermates (n=29) had blood glucose
levels of 168±11 mg/dL. By 400 days, the average blood glucose
levels of uninfected and scrapie-infected GPI−/− PrP tg mice were
equivalent (173±13 or 173±17 mg/dL, respectively). Glucose
tolerance tests performed on eleven individual GPI−/− PrP tg mice,
six infected with scrapie and ﬁve non-infected age- and sex-matched
C57Bl/6 controls, showed less than a 2-fold increase in blood glucose
levels over the pre-challenge level at 1, 4, 6, or 24 h after challenge
with 2 mg/kg of glucose intravenously, while in contrast, 3 of 3 NOD
Fig. 3. Deposition of PrP in the islets of GPI−/− transgenic mice. Pancreas isolated from PrP knockout mice (PrP−/−), B6 mice, or GPI−/− transgenic mice infected with 2% scrapie
intracranially was sectioned and stained for PrP as described in Materials and methods. PrP was detected only in the islets of the pancreas, not in the acinar cells, in the GPI−/− PrP tg
mice. No PrP was detected in the pancreas of PrP−/− mice or in B6 mice infected with scrapie at 160 days post-infection. Arrows indicate the Islets of Langerhans in the tissues.
Images of the islets from GPI−/− PrP tg mice were taken at 200× and 400× magniﬁcation. Control tissues are shown at 50× magniﬁcation.
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glucose levels at the earlier time points. Given the lack of an abnormal
increase in blood glucose levels and the presence of insulin in the
islets during PrP infection, we determined that infection with PrPsc
does not result in defects in glucose metabolism.PrP deposits primarily in the α-cells of the islets of Langerhans with
some β-cell involvement
In the last series of studies we used high-resolution electron
microscopy to identifywhich islet cells contained PrP deposits. GPI−/−
PrP tg mice were sacriﬁced at 500 days post-infection and brain
(positive control for amyloid and PrP deposits) and pancreas sections
were prepared for immuno-electron microscopy as in Materials and
methods. The sections were labeled with the D18 monoclonal
antibody to PrP and visualized with protein A-coupled 10 nm gold
particles. For the brain as a positive control, we investigated PrP
staining and amyloid deposition in the hippocampus (Fig. 6A). For the
pancreas, we investigated PrP staining in the islets of Langerhans with
uninfected B6 and GPI−/− mice as negative controls (Fig. 6B). The
10 nm gold particles appear as black dots in the electron micrographs
indicating the presence of PrP. Large areas of extracellular ﬁbrillar
material composed of prion protein were observed in the hippocam-
pus of the infected GPI−/− PrP tg mice brains (Fig. 5A). These
aggregates were located mainly around small blood vessels and
capillaries. No amyloid was found in uninfected transgenic GPI−/− PrP
tg mice or B6 mice (data not shown). The acquired high-resolution
data conﬁrms the histological ﬁndings previously reported (Chesebroet al., 2005; Triﬁlo et al., 2008). Fibrillar aggregates of PrP were also
found peri-nuclear in hippocampal cells (not shown). The close
proximity (100 nm) to the nucleus and the frequency of this ﬁnding
suggest that PrP aggregation may not only occur extracellularly but
also intracellularly, possibly in the secretory and/or endocytotic
pathways of the cell.
When the endocrine portion of the islets of Langerhans in the
pancreas was studied with respect to PrP, immunolabeling was
detected in both α- and β-cells in the islets but in different cellular
compartments. In α-cells, a very speciﬁc and strong labeling was
observed in the core of the secretory granules while reactivity was
detected only in the cytosol of β-cells (Fig. 6B, top panels). No signs of
cell apoptosis or amyloid deposits were observed in the islets,
consistent with negative thioﬂavin S and Congo Red stains in the
islets of GPI−/− PrP tg mice infected with scrapie, and the islets of
uninfected GPI−/− PrP tg mice showed less labeling for PrP, while
uninfected B6 mice did not label for PrP (Fig. 6B, bottom panels).
Owing to the conditions required to obtain high tissue/cell resolution
for immuno-electron microscopy, we could not treat the tissue with
proteinase K to determinewhether the PrP observed in the positiveα-
or β-cells is PrPc, PrPsc, or both. Attempts to do so using histoblots of
infected tissue were inconclusive, with positive staining for PrPsc
found in the brain but not reliably in the pancreas of infected mice.Discussion
In this study, we report three novel observations. First, extraneural
manifestations of PrPsc occur in the kidney, pancreas, eye, skeletal
Fig. 4. Insulin production occurs in the presence of PrPsc deposition. The expression of insulin in the islets of GPI−/−mice infected with scrapie was examined by immunoﬂuorescence
microscopy. As shown, despite the presence of large amounts of PrPsc in the islets (red), there is a signiﬁcant amount of insulin production (green). The overlay panel shows colocalization
(yellow) of both molecules. The top panels show staining with the primary and secondary antibodies for insulin or PrP, as indicated, while the bottom panels show background staining
with the secondary antibody only. No non-speciﬁc background is noted. These observationsweremade on tissues from four independent GPI−/− PrP tgmice infectedwith scrapie. Images
were taken at 400× magniﬁcation.
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Second, focus on the gut and kidney revealed deposition of PrP and
infectiousmaterial in these tissues resulted in infectious transmissible
material in the corresponding excreta, feces and urine. Third, in the
pancreas PrP is found exclusively in the islets of Langerhans, primarily
in the α-cells but also in the β-cells of the islets and not in the acinar
cells. The pancreas also contains infectious transmissible material.
While RML scrapie induces amyloid deposits in brain, heart and gut, it
fails to do so in the islets of Langerhans. Despite PrP involvement in
the kidneys and islets, neither abnormal proteinuria nor abnormal
glucose metabolism occurred.
Deposition of PrPsc in the GPI−/− anchorless mouse following
scrapie infection appeared in several peripheral tissues, consistent
with previous observations using 22L scrapie in the GPI model system
(Race et al., 2008), and with studies of scrapie-induced diabetes in
hamsters (Srinivasappa et al., 1989). Levels of PrPsc vary depending
on the tissue, as observed in all tissues tested except the thymus. The
consequences of deposits of PrPsc and amyloid in the brain and heartFig. 5. PrP deposition in the pancreas of scrapie-infected GPI−/− PrP tg mice is infectious. Pan
tga20mice (shown) or B6 mice (not shown) intracranially. Mice were sacriﬁced when displa
PrP protein. C57Bl/6J (B6) mice are shown as both negative and positive controls for conversi
mice exhibited clinical manifestations of prion disease, and brain isolates from these micein GPI−/− PrP tg mice infected with scrapie lead to abnormal neuron
conduction and cognitive function in the CNS (Triﬁlo et al., 2008) and
left ventricular failure when ﬂuid load was increased in the heart
(Triﬁlo et al., 2006). In agreement with our ﬁndings in GPI−/− PrP tg
mice infected with scrapie, PrPsc deposition in the kidney leads to
infectious material being shed into the urine and that PrPsc in the gut
leads to fecal infectivity, urine, feces, and milk have been shown to be
able to transmit scrapie in cows, sheep, goats, deer, and hamsters
(Didier et al., 2008; Haley et al., 2009; Kariv-Inbal et al., 2006; Lacroux
et al., 2008; Maddison et al., 2009; Safar et al., 2008). The recent report
of GPI-anchorless prion protein in human patients (Jansen et al.,
2010) suggests that it may be possible for similar extraneural
manifestations to occur in man.
PrP deposited in the islets of Langerhans but was not detected in
acinar cells. Using electron microscopy with immunogold labeling of
PrP, we determined that in GPI−/− PrP tg mice, PrP labeling occurs
primarily within the α-cells of the islet, also with β-cell involvement.
Despite PrP localization solely in the islets, we observed no effect oncreas or brain was taken from different mice (termed inoculum above) and injected into
ying clinical signs of prion disease and brain samples were analyzed byWestern blot for
on of PrPc into PrPsc. Tga20mice injected with inoculum from different GPI−/− infected
were positive for PrPsc by Western blot.
Fig. 6. Electron microscopy of PrP in brain and islet cells of the pancreas. (A) PrP stained with D18 monoclonal antibody coupled to immunogold is visible in the hippocampus of GPI−/−
mice infected with RML scrapie i.c. The right panel is a magniﬁcation of the region outlined with a dotted square on the left. Arrows point to PrP-labeled amyloid ﬁbrils. (B) PrP is seen
predominantly in the alpha cells of the pancreas in infectedGPI−/−micewith deposition also noted in the beta cells (top panels). Little or no deposition is noted in uninfectedmice, either
GPI−/− (middle panels) or wild-type B6 (lower panels). The panels to the right aremagniﬁcations of the region outlinedwith a dotted square in each ﬁgure. Arrows point to gold-labeled
PrP in the cells of the islets. The white scale bars are 2 μm, while the black scale bars are 500 nm.
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a result inconsistent with infection in hamsters that results in
signiﬁcant alterations in both (Srinivasappa et al., 1989). It appears
that the extraneural deposition of PrPsc in the islets does not have the
same functional consequence as does deposition in the brain and
heart. Of interest is that amyloid deposits associated with the CNS and
heart in PrPsc deposition did not occur in the islets of Langerhans. In
the islets, incorrectly folded PrPsc may undergo degradation or be
secreted into the blood, preventing a critical concentration needed for
ﬁbril formation to occur.
Extraneural evidence that PrPsc can occur as an amyloid depositwas
found in the gut (Fig. 2). We showed that excreta from these mice
contain PrPsc (Fig. 2D) and transmitted infectiousmaterial as did tissue
from the pancreas of infected GPI−/− PrP tgmice (Figs. 2B, 5). However,
since theirweights and survivalwere no different thanuninfectedGPI−/−PrP tg mice and their feces was not abnormal, any defect in scrapie-
infected GPI−/− PrP tg mice likely would be modest. It has been
suggested that PrP infection may be transferred horizontally in the
excreta of mice (Seeger et al., 2005), as has been demonstrated in cervid
models of chronic wasting disease (Haley et al., 2009; Mathiason et al.,
2006). We demonstrate that mouse excreta can harbor infectious PrPsc,
which conﬁrms previous results with other rodent transgenic models
(Miller et al., 2004), and demonstrates that anchorless PrP has the
potential to be a transferrable scrapie agent.
Amyloid deposits do occur in other diseases of the pancreas, most
notably type 2 diabetes (Clark et al., 1987; Lorenzo et al., 1994).
Deposition of amyloid ﬁbrils in the pancreatic islets of Langerhans is a
common pathological manifestation associated with type 2 diabetes
and is called islet amyloidosis. The ﬁbrillogenic peptide amylin/IAPP
(islet amyloid polypeptide) is produced and secreted in concert with
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β-cell death and progression of hyperglycaemia (Hoppener and Lips,
2006;Westermark et al., 1986). Islet amyloid occurs during prolonged
beta-cell stress and no or little amyloid can be detected in healthy
subjects even though amylin is very amyloidogenic, suggesting a
highly developed cellular capacity to handle misfolding and aggre-
gating proteins and peptides (Clark et al., 1995; Murray et al., 2010;
Narita et al., 1992). The ﬁnding of PrP in the islets and transmission of
infectious material without evidence of amyloid ﬁbrils was unex-
pected given that PrP deposits readily as amyloid in other tissues
(Chesebro et al., 2005; Triﬁlo et al., 2006). In addition there were no
signs of apoptosis or recruitment of macrophages or lymphocytes to
the islets of GPI−/− PrP tg mice infected with scrapie. Perhaps the
failure of amyloid formation in GPI−/− PrP tg mice infected by RML
scrapie is prevented by cellular mechanisms for disaggregation by the
highly specialized hormone producing islet cells (Clark et al., 1995;
Murray et al., 2010; Narita et al., 1992).
Jansen and colleagues recently detailed two cases of human prion
protein misfolding diseases that coincided with a loss of the GPI anchor
via a stop codon mutation (Jansen et al., 2010). Their ﬁndings not only
support use of the GPI−/− PrP tg mouse model to assess the effects of
prion infection but suggest that extraneural manifestations may also
occur in human cases. While this has been reported for one case of
dilated cardiomyopathy (Ashwath et al., 2005), it has not yet been
analyzed in the human genetic mutations described by Jansen et al.
(Jansen et al., 2010).
Materials and methods
Scrapie inoculation of mice
A transgenic mouse line heterozygous for PrP (Tg line 44) lacking a
GPI anchor (GPI−/−PrP tgmice),was created, genotyped, and infectedas
describedpreviously (Chesebro et al., 2005).When infectedwithmurine
scrapie, thesemice developed PrPsc amyloid deposits and infectious PrP
material but not clinical neurodegenerative disease. C57BL/6, C57Bl/10
(wild-type), and tga20 mice were obtained from the Rodent Breeding
Colony at The Scripps Research Institute. The tga20 mice (PrP over-
expressers) were used for infectivity studies and as controls. Infection
was induced by inoculating transgenic, wild-type, and Tga20 mice
intracerebrally at 6 weeks of age with 30 μl of a 1% suspension of brain
tissue or pancreatic from GPI−/− PrP tg mice and GPI+/+ PrP mice
infected with RML (Chandler) scrapie. Only wild-type and Tga20 mice
exhibit signs of CNS disease and dysfunction following scrapie infection
at 150–160 days and 50–60 days post-infection, respectively. These
clinical signs include weakness, lassitude, ataxia, and paralysis, with
death resulting from scrapie infection shortly after the onset of these
symptoms. These CNS signs of scrapie infection are absent in the GPI−/−
PrP tg mice during their lifespan.
Immunohistochemistry and immunoﬂuorescence staining
Immunohistochemistry and immunoﬂuorescence staining were
performed essentially as described (Chesebro et al., 2005). Brieﬂy,
tissueswereﬁxed in a neutral-buffered 4% formaldehyde solution for 3–
5 days, dehydrated, embedded in parafﬁn and cut into 4-μMsections on
glass slides using a Leica microtome. Slides were deparafﬁnized and
rehydrated in xylene and alcohol rinses, and autoclaved for 15 min at
20 p.s.i. and 120 °C for retrieval of PrP antigen. Samples were incubated
with25 μg/mLproteinaseK for 1 h at room temperature to remove PrPc,
blocked in 2% BSA and stained for PrPsc using 3 μg/mL D13 antibody
(Chesebro et al., 2005; Matsunaga et al., 2001). For double immunoﬂu-
orescence staining (Oldstone et al., 1983), a FITC-conjugated donkey
antibody to mouse insulin and the mouse antibody D13 (Matsunaga et
al., 2001) conjugated to rhodamine were used. After overnight
incubation with the primary antibody, slides were rinsed with bufferand stained with a 1:200 solution of biotinylated goat anti-human
antiserum. Streptavidin-conjugated rhodamine or horseradish peroxi-
dase followed by Ventana aminoethylcarbazol was used for immuno-
ﬂuorescence or light microscopy, respectively. Staining for amyloid was
performed using 1% w/v Thioﬂavin S (MP Biomedicals) in 50% ethanol.
Slides were rinsed twice in 50% ethanol and twice in water prior to
mounting and coverslipping. Staining of PrPsc and amyloid was
observed using an Axiovert S100 microscope (Zeiss).Immuno-gold electron microscopy
GPI−/− PrP tg mice infected with RML scrapie i.c. were sacriﬁced
500 days post-infection, alongwith agematched uninfected GPI−/− PrP
tg and B6 mice. Brain and pancreatic tissues were harvested from these
mice and immediately ﬁxed in a PBS/2% paraformaldehyde/0.25%
glutaraldehyde solution for 24 h. Following ﬁxation, the tissue was
washed in PBS and dehydrated through a series of graded ethanol
solutions followed by propylene oxide. The tissue was embedded in an
Epon/Araldite mixture (Electron Microscopy Sciences, Hatﬁeld, PA) for
sectioning. The resin-embedded tissue was sectioned at 70 nm and
mounted on uncoated 400 mesh nickel grids (Electron Microscopy
Sciences, Hatﬁeld, PA) for immunolabeling. Antigen retrieval was
performed by incubating samples in a saturated aqueous solution of
sodium m-periodate for 10 min followed by a wash in Tris-buffered
saline (TBS; 50 mM Tris–HCl, pH 7.4, 150 mM NaCl). Tissue sections
were blocked in 3% bovine serum albumin (BSA) in TBS for 30 min,
followed by an overnight incubation at room temperature with a 1:50
dilution of D18 monoclonal antibody (human anti-PrP, (Matsunaga et
al., 2001)) in TBS/1%BSA. Sectionswerewashed 3× in TBS and blocked a
second time in TBS/3% BSA for 30 min, followed by a 2-hour incubation
at room temperature in a 1:100 solution of protein A conjugated to
10 nm gold particles (PAG10 BB International, Cardiff, UK) in TBS/1%
BSA. The sectionswere rinsed 3 times in TBS, 3 times in water, air dried,
and then contrasted with 2% uranyl acetate in 50% ethanol for 10 min
and in Reynold's lead citrate solution (120 mmol/L sodium citrate,
25 mmol/L lead nitrate ) for 1.5 min. Specimens were studied in a Jeol
100CX electron microscope (Jeol, Akishima, Tokyo, Japan) at 100 kV,
and electron micrographs were taken with a Mega View III CCD camera
linked to Analysis Pro v3.2 digital micrograph software (Soft Imaging
System GmbH, Muenster, Germany).Western blot analysis of PrP infection
Brain, kidney, spleen, thymus, eye, skeletal muscle, gut, heart, and
pancreatic tissues were harvested from GPI−/− PrP tg mice infected
with RML scrapie at day 400 post-infection. A 2% homogenate of each
was made in PBS and prepared for Western blot as described
(Chesebro et al., 2005; Triﬁlo et al., 2006, 2008). To assay
transmission of infectivity, Tga20micewere inoculated intracranially
with 30 μL of the 2% homogenate of the tissues, and brain tissue was
harvested from these mice when clinical manifestations of prion
disease became apparent (50–70 days post-infection). The presence
of conversion of PrPc to PrPsc was conﬁrmed by both Western blot
and immunohistochemistry (Chesebro et al., 2005; Oldstone et al.,
1983; Triﬁlo et al., 2006, 2008). Brieﬂy, for Western blots, tissues
were homogenized and subjected to digestion with proteinase K
(50 μg/mL) for 1 h at 37 °C Total protein in the processed homoge-
natewas quantiﬁed by a colorimetric BCA assay (Pierce), and 20 μg of
total protein was loaded per lane in a 16% SDS-PAGE gel. Samples
were electrophoresed, blotted to PVDF membrane, and probed for
PrP with a 3 μg/mL solution of D13 human anti-PrP antibody
(Matsunaga et al., 2001) followed by a peroxidase-coupled anti-
human IgG secondary antibody. Blots were developed using Super
Signal ECL detection (Pierce).
8 A.M. Lee et al. / Virology 411 (2011) 1–8Blood glucose measurements
Blood samples were obtained from the retroorbital plexus of mice.
Plasma glucose was determined using a One-Touch Ultra glucose
meter (Life Scan) as reported (Horwitz et al., 2009). Glucose tolerance
tests were performed on mice deprived of food for 18 h. Mice were
pre-bled and then given 2 mg/kg glucose intravenously and bled at 1,
4, 6, and 24 h following glucose injection as previously reported
(Oldstone et al., 1984).
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